Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1601 Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions.
 		Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2009
1602 Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.
 		Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1603 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2009
1604 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Radiotherapy and Nuclear medicine Prof. Mohammed Abdel-Hamid Ahmed Suleiman 2009
1605 Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: an animal experiment Department of Surgical Oncology Dr. Anwar Tawfik Amin 2009
1606 Anti-angiogenic cancer therapy updates Department of Medical Oncology Dr. Arwa Mohamed Ali Abdel-Mawjod 2009
1607 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2009
1608 A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1609 Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2008
1610 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2008